- McNeil unveils 'Smiling it Forward' campaign in support of Tylenol
- FDA recommends health professionals prescribe no more than 325 mg of acetaminophen per dose
- Consumer trust intact as McNeil brands like Tylenol return back to shelf
- Prestige Brands solution to pediatric overdosing — unique squeezable, single-dose APAP packet
- FDA advisory panel to consider OTC status of NSAIDs
FORT WASHINGTON, Pa. — McNeil Consumer Healthcare on Tuesday recalled one product lot of the analgesic Tylenol 8 Hour extended-release caplets 150-count bottles distributed in the United States, and three brands at the wholesale level.
“McNeil is taking this action as part of our ongoing surveillance and monitoring efforts that identified a small number of complaints of a musty or moldy odor,” the company stated, specifically referencing only the Tylenol 8 Hour recall. The lot number found on the label on the side of the bottle is ADM074; UPC Code 300450297181.
Consumers who purchased product from the lot included in this recall should stop using the product and contact McNeil Consumer Healthcare, either at Tylenol.com or by calling (888) 222-6036.
The uncharacteristic odor is thought to be caused by the presence of trace amounts of chemicals called 2,4,6-tribromoanisole, or TBA, and 2,4,6-trichloroanisole, or TCA.
Separately, McNeil Consumer Healthcare is adding 10 lots of other products to a wholesale level recall the company originally initiated on Jan. 14. That recall was conducted as a precautionary measure after a review of past production records found instances where equipment cleaning procedures were insufficient or that cleaning was not adequately documented. That recall did not require any action by consumers or healthcare providers.
For a list of the additional lot numbers included in the latest recall, click here.